BARDS is a critical partner in accelerating end-to-end product research, development, regulatory approval and patient access implementation by collaborating with other scientists to help deliver medicines and vaccines that can change the world. Our work is vital to advancing a diverse pipeline, which includes vaccines and products for oncology, infectious diseases, cardio-metabolic disorders and more.